<DOC>
	<DOCNO>NCT02894112</DOCNO>
	<brief_summary>Epidemiological study indicate risk type 2 diabetes low milk consume regular diet . Milk product unique produce high insulin response despite low glycemic index . The general aim propose study determine effect fluid milk attenuate postprandial surge plasma glucose triglyceride meal associate physiological mechanism . The investigator hypothesize consumption one two serving non-fat milk add standard oral glucose tolerance test ( OGTT ) solution high fat tolerance test meal attenuate postprandial hyperglycemia triglyceridemia . The investigator hypothesize postulated improvement postprandial metabolic response due consumption fluid milk associate increased postprandial insulin secretion well insulin-mediated endothelial vasodilation whole-limb perfusion .</brief_summary>
	<brief_title>Effects Fluid Milk Attenuating Hyperglycemia Hypertriglyceridemia After Meal</brief_title>
	<detailed_description>A double blind randomize placebo-controlled crossover experimental design six treatment use . A total 30 young ( 20-40 year old ) healthy men woman serve subject . Following 2 day physical activity dietary control , subject consume standard OGTT load high fat tolerance load morning Day 3 . The solution use meal mixed one two serving non-fat milk placebo ( either carbohydrate matched total calorie match ) . Before test meal consume , blood sample obtain later analysis glucose , triglyceride , insulin , inflammatory cytokine brachial artery flow-mediated dilation femoral artery vascular conductance measure . The present research project provide new clinically useful insight role conventional dairy product metabolic homeostasis . If working hypothesis support , information could use initial/preliminary basis recommendation consumption fluid milk prevention metabolic disease .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Apparently health , sedentary . All subject BMI 2535 kg/m2 . Candidates take cardiovascularacting drug eligible participation . Subjects significant intimamedia thickening , plaque formation , characteristic atherosclerosis , metabolic disease , gastrointestinal disorder , and/or renal disease exclude study . Additional exclusion criterion cow milk allergy lactose intolerance , pregnancy lactation , alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>endothelial dependent vasodilation</keyword>
	<keyword>blood flow</keyword>
	<keyword>blood glucose</keyword>
	<keyword>triglyceride</keyword>
	<keyword>non-fat milk</keyword>
	<keyword>dairy</keyword>
</DOC>